Please login to the form below
Combination therapies
This page shows the latest Combination therapies news and features for those working in and with pharma, biotech and healthcare.
NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
The positive recommendation by NICE should increase clinician confidence in using a combination of therapies in this setting.”.
Latest news
-
STORM Therapeutics receives Innovate UK grant
STORM Therapeutics, a University of Cambridge spin-out specialising on small molecule therapies targeting RNA epigenetic mechanisms, has been awarded a Biomedical Catalyst grant by Innovate UK. ... This new treatment option could be used to treat
-
Gilead’s Veklury significant decreases risk of hospitalisation for COVID-19 patients
This analysis found that more than half of hospitalised COVID-19 patients received Veklury in combination with other therapies.
-
Gilead to pay $745m for three oncology programmes from Arcus Biosciences
with Trodelvy (sacituzumab govitecan-hziy) in combination with optioned Arcus therapies.
-
Gilead sales rise by 13%, buoyed by anti-COVID-19 drug Veklury
Without the Veklury bump, total product sales decreased by 3% to $5.4bn for the third quarter, primarily due to the loss of exclusivity of HIV combination therapies Truvada (emtricitabine/tenofovir
-
FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
Also, two clinical trials involving combination therapies – involving both Tivdak and Merck’s Keytruda – have shown encouraging results.
More from news
Approximately 0 fully matching, plus 113 partially matching documents found.
Latest Intelligence
-
A snapshot of… Enterprise Therapeutics
The company envisages that its drugs will be effective as monotherapies and in combination with other CF therapies including CFTR modulators. ... We are fortunate that Enterprise is well positioned and funded by a combination of private investors and the
-
Detecting Alzheimer’s ahead of a cure
Many are now coming to the same conclusion: that a combination of different therapies and detection methods could be the answer to fighting Alzheimer’s. ... Alzheimer’s Research UK is launching head first into the fight, with a new drive towards
-
Where next in Alzheimer’s disease R&D?
disease. Targeting tau. Tau is among the beneficiaries of the broader focus and emerging interest in combination therapies. ... These mechanisms may be complementary. “We think combination therapies between. antibodies and small molecules make a lot of
-
Combining therapies and combining research
create new super-resistant combination therapies. ... This crucial observation was followed by combination therapies for other major disease areas such as AIDS and cancer.
-
Combined immunotherapies – potential and pitfalls
Efforts to prevent resistance are also driving interest in combination therapies, said Matthew Galsky, MD, professor of medicine, haematology and medical oncology, Mount Sinai Hospital in New York. ... The risk of autoimmune responses or toxicities, and
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
What does the future hold for Light-chain Amyloidosis?
In the absence of approved therapies, the treatment strategy being adopted was very much aligned with that recommended for Multiple Myeloma, with Velcade (bortezomib), used in combination with cyclophosphamide and dexamethasone ... For example, more than
-
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)
However, the emergence of anti-programmed cell death protein 1/ligand 1 (PD-[L] 1) therapies, particularly in combination with locoregional therapies that can target these suppressive barriers, may provide meaningful ... TILs) to Tregs as well as M2
-
Combination therapies in oncology: The benefits of integrated insights
In association with Pharmaceutical Executive. Register now: . Most experts believe combination therapies to be the future of oncology treatment. ... Understand how KOLs see oncology market evolving and how combination therapies will be utilized.
-
Research Partnership
Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies. ... Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies.
More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Janssen announces positive results supporting Rybrevant and lazertinib combination treatment for NSCLC
- Medscape Education Receives Joint Accreditation with Commendation to Deliver Continuing Education for Healthcare Providers
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
- NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
- Sanofi and Innovent Biologics to develop oncology drugs for patients in China
- WHO launches funding appeal for greater Horn of Africa prompted by food crisis
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- Animation: Living With
- The journey from the patient's perspective...
- Achieving communication excellence by targeting the right channel at the right time
- By Danny Buckland...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
